BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 16038267)

  • 21. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effect of alpha-galactosylceramide-loaded dendritic cells genetically engineered to express SLC/CCL21 along with tumor antigen against peritoneally disseminated tumor cells.
    Matsuyoshi H; Hirata S; Yoshitake Y; Motomura Y; Fukuma D; Kurisaki A; Nakatsura T; Nishimura Y; Senju S
    Cancer Sci; 2005 Dec; 96(12):889-96. PubMed ID: 16367909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
    Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
    J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells.
    Kitamura H; Ohta A; Sekimoto M; Sato M; Iwakabe K; Nakui M; Yahata T; Meng H; Koda T; Nishimura S; Kawano T; Taniguchi M; Nishimura T
    Cell Immunol; 2000 Jan; 199(1):37-42. PubMed ID: 10675273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of cyclosporin A on the activation of natural killer T cells induced by alpha-galactosylceramide.
    Kajiwara T; Tomita Y; Okano S; Iwai T; Yasunami Y; Yoshikai Y; Nomoto K; Yasui H; Tominaga R
    Transplantation; 2007 Jan; 83(2):184-92. PubMed ID: 17264815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phenotypical and functional alterations during the expansion phase of invariant Valpha14 natural killer T (Valpha14i NKT) cells in mice primed with alpha-galactosylceramide.
    Ikarashi Y; Iizuka A; Koshidaka Y; Heike Y; Takaue Y; Yoshida M; Kronenberg M; Wakasugi H
    Immunology; 2005 Sep; 116(1):30-7. PubMed ID: 16108815
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human CD4+ CD25+ regulatory T cells suppress NKT cell functions.
    Azuma T; Takahashi T; Kunisato A; Kitamura T; Hirai H
    Cancer Res; 2003 Aug; 63(15):4516-20. PubMed ID: 12907625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dendritic cell maturation by CD11c- T cells and Valpha24+ natural killer T-cell activation by alpha-galactosylceramide.
    Ishikawa E; Motohashi S; Ishikawa A; Ito T; Uchida T; Kaneko T; Tanaka Y; Horiguchi S; Okamoto Y; Fujisawa T; Tsuboi K; Taniguchi M; Matsumura A; Nakayama T
    Int J Cancer; 2005 Nov; 117(2):265-73. PubMed ID: 15900581
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Detection and activation of human Valpha24+ natural killer T cells using alpha-galactosyl ceramide-pulsed dendritic cells.
    Fujii S; Shimizu K; Steinman RM; Dhodapkar MV
    J Immunol Methods; 2003 Jan; 272(1-2):147-59. PubMed ID: 12505720
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A phase I study of in vitro expanded natural killer T cells in patients with advanced and recurrent non-small cell lung cancer.
    Motohashi S; Ishikawa A; Ishikawa E; Otsuji M; Iizasa T; Hanaoka H; Shimizu N; Horiguchi S; Okamoto Y; Fujii S; Taniguchi M; Fujisawa T; Nakayama T
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6079-86. PubMed ID: 17028247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potent expansion of human natural killer T cells using alpha-galactosylceramide (KRN7000)-loaded monocyte-derived dendritic cells, cultured in the presence of IL-7 and IL-15.
    van der Vliet HJ ; Nishi N; Koezuka Y; von Blomberg BM ; van den Eertwegh AJ ; Porcelli SA; Pinedo HM; Scheper RJ; Giaccone G
    J Immunol Methods; 2001 Jan; 247(1-2):61-72. PubMed ID: 11150537
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prolonged IFN-gamma-producing NKT response induced with alpha-galactosylceramide-loaded DCs.
    Fujii S; Shimizu K; Kronenberg M; Steinman RM
    Nat Immunol; 2002 Sep; 3(9):867-74. PubMed ID: 12154358
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mice deficient in Vbeta8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction.
    Habu Y; Shinomiya N; Kinoshita M; Matsumoto A; Kawabata T; Seki S
    Clin Exp Med; 2007 Mar; 7(1):30-8. PubMed ID: 17380303
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells.
    Carnaud C; Lee D; Donnars O; Park SH; Beavis A; Koezuka Y; Bendelac A
    J Immunol; 1999 Nov; 163(9):4647-50. PubMed ID: 10528160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A distinct subset of natural killer T cells produces IL-17, contributing to airway infiltration of neutrophils but not to airway hyperreactivity.
    Lee KA; Kang MH; Lee YS; Kim YJ; Kim DH; Ko HJ; Kang CY
    Cell Immunol; 2008 Jan; 251(1):50-5. PubMed ID: 18423430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-18 regulates T helper 1 or 2 immune responses of human cord blood CD4+ V alpha 24+V beta 11+ natural killer T cells.
    Fujibayashi Y; Fujimori Y; Kasumoto I; Kai S; Hara H; Okamura H; Tsutsui H; Ogawa H; Nakanishi K
    Int J Mol Med; 2007 Aug; 20(2):241-5. PubMed ID: 17611643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mediastinal lymph node CD8alpha- DC initiate antigen presentation following intranasal coadministration of alpha-GalCer.
    Ko SY; Lee KA; Youn HJ; Kim YJ; Ko HJ; Heo TH; Kweon MN; Kang CY
    Eur J Immunol; 2007 Aug; 37(8):2127-37. PubMed ID: 17615581
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K; Exley MA; Jiang X; Ohkochi N; Taniguchi M; Seino K
    Cancer Res; 2006 Dec; 66(23):11441-6. PubMed ID: 17145891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.
    Giaccone G; Punt CJ; Ando Y; Ruijter R; Nishi N; Peters M; von Blomberg BM; Scheper RJ; van der Vliet HJ; van den Eertwegh AJ; Roelvink M; Beijnen J; Zwierzina H; Pinedo HM
    Clin Cancer Res; 2002 Dec; 8(12):3702-9. PubMed ID: 12473579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Expansion and cytokine secretion profile of human valpha24(+) NKT cells from different sources].
    Zhai WH; Huang Y; Wang M; Zhou Z; Zhai WJ; Zhang RL; Zhang P; Han MZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Jun; 17(3):633-6. PubMed ID: 19549378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.